Responses
Poster Presentations
Rheumatoid arthritis - non biologic treatment
THU0214 Long-term outcome of iguratimod, conventional synthetic disease-modifyng anti-rheumatic drud developed in japan, in japanese patients with rheumatoid arthritis in real-world clinical setting
Compose a Response to This Article
Other responses
No responses have been published for this article.